BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 10722675)

  • 1. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model.
    Taghibiglou C; Carpentier A; Van Iderstine SC; Chen B; Rudy D; Aiton A; Lewis GF; Adeli K
    J Biol Chem; 2000 Mar; 275(12):8416-25. PubMed ID: 10722675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepatic insulin sensitivity.
    Mangaloglu L; Cheung RC; Van Iderstine SC; Taghibiglou C; Pontrelli L; Adeli K
    Metabolism; 2002 Apr; 51(4):409-18. PubMed ID: 11912545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster.
    Carpentier A; Taghibiglou C; Leung N; Szeto L; Van Iderstine SC; Uffelman KD; Buckingham R; Adeli K; Lewis GF
    J Biol Chem; 2002 Aug; 277(32):28795-802. PubMed ID: 12048212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance.
    Taghibiglou C; Rashid-Kolvear F; Van Iderstine SC; Le-Tien H; Fantus IG; Lewis GF; Adeli K
    J Biol Chem; 2002 Jan; 277(1):793-803. PubMed ID: 11598116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rosuvastatin on hepatic production of apolipoprotein B-containing lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia.
    Chong T; Naples M; Federico L; Taylor D; Smith GJ; Cheung RC; Adeli K
    Atherosclerosis; 2006 Mar; 185(1):21-31. PubMed ID: 16002078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction.
    Haidari M; Leung N; Mahbub F; Uffelman KD; Kohen-Avramoglu R; Lewis GF; Adeli K
    J Biol Chem; 2002 Aug; 277(35):31646-55. PubMed ID: 12070142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
    Qin B; Anderson RA; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular mechanisms regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes.
    Taghibiglou C; Rudy D; Van Iderstine SC; Aiton A; Cavallo D; Cheung R; Adeli K
    J Lipid Res; 2000 Apr; 41(4):499-513. PubMed ID: 10744770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster.
    Lewis GF; Uffelman K; Naples M; Szeto L; Haidari M; Adeli K
    Endocrinology; 2005 Jan; 146(1):247-55. PubMed ID: 15486228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance.
    Adeli K; Taghibiglou C; Van Iderstine SC; Lewis GF
    Trends Cardiovasc Med; 2001 Jul; 11(5):170-6. PubMed ID: 11597827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both insulin resistance and diabetes in Psammomys obesus upregulate the hepatic machinery involved in intracellular VLDL assembly.
    Zoltowska M; Ziv E; Delvin E; Lambert M; Seidman E; Levy E
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):118-23. PubMed ID: 14604833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
    Basciano H; Miller A; Baker C; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G323-32. PubMed ID: 19497957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of cytosolic triacylglycerol recruitment for very low density lipoprotein assembly by inactivation of microsomal triglyceride transfer protein results in a delayed removal of apoB-48 and apoB-100 from microsomal and Golgi membranes of primary rat hepatocytes.
    Hebbachi AM; Brown AM; Gibbons GF
    J Lipid Res; 1999 Oct; 40(10):1758-68. PubMed ID: 10508195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone improves intestinal lipoprotein overproduction in the fat-fed Syrian Golden hamster, an animal model of nutritionally-induced insulin resistance.
    Leung N; Naples M; Uffelman K; Szeto L; Adeli K; Lewis GF
    Atherosclerosis; 2004 Jun; 174(2):235-41. PubMed ID: 15136053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
    Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
    Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related kinase, and sterol regulatory element-binding protein-1c in the fructose-fed hamster intestine.
    Federico LM; Naples M; Taylor D; Adeli K
    Diabetes; 2006 May; 55(5):1316-26. PubMed ID: 16644688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of metabolic dyslipidemia in insulin resistant states: deregulation of hepatic and intestinal lipoprotein secretion.
    Avramoglu RK; Qiu W; Adeli K
    Front Biosci; 2003 Jan; 8():d464-76. PubMed ID: 12456312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal assembly and secretion of highly dense/lipid-poor apolipoprotein B48-containing lipoprotein particles in the fasting state: evidence for induction by insulin resistance and exogenous fatty acids.
    Guo Q; Avramoglu RK; Adeli K
    Metabolism; 2005 May; 54(5):689-97. PubMed ID: 15877301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal development of hepatocellular apolipoprotein B assembly and secretion in the rat.
    Plonné D; Schulze HP; Kahlert U; Meltke K; Seidolt H; Bennett AJ; Cartwright IJ; Higgins JA; Till U; Dargel R
    J Lipid Res; 2001 Nov; 42(11):1865-78. PubMed ID: 11714856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster.
    Arbeeny CM; Meyers DS; Bergquist KE; Gregg RE
    J Lipid Res; 1992 Jun; 33(6):843-51. PubMed ID: 1512511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.